WYE-687


CAS No. : 1062161-90-3

WYE-687,1062161-90-3
Product Details
For research use only. Not Intended for Therapeutic Use!
Cat No:I000312
Synonyms:methyl N-[4-[4-morpholin-4-yl-1-[1-(pyridin-3-ylmethyl)piperidin-4-yl]pyrazolo[3,4-d]pyrimidin-6-yl]phenyl]carbamate
Molecular Formula:C₂₈H₃₂N₈O₃
Molecular Weight:528.61
Target:mTOR
IC50:7 nM
Price:Get quote
We would like to match the lowest price on market if possible.

Your information is safe with us.

refresh
Appearance:white solid powder
Purity: > 98%
Cat No:I000312
Cas No:1062161-90-3
Product-Name:WYE-687
MDL No:MFCD22417086
InChI:InChI=1S/C28H32N8O3/c1-38-28(37)31-22-6-4-21(5-7-22)25-32-26(35-13-15-39-16-14-35)24-18-30-36(27(24)33-25)23-8-11-34(12-9-23)19-20-3-2-10-29-17-20/h2-7,10,17-18,23H,8-9,11-16,19H2,1H3,(H,31,37)
InChIKey:VDOCQQKGPJENHJ-UHFFFAOYSA-N
SMILES:COC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCN(CC4)CC5=CN=CC=C5)C(=N2)N6CCOCC6

WYE-687 is an ATP-competitive and selective inhibitor of mTOR with IC50 of 7 nM; > 100 fold selectivity for mTOR than PI3Kα/γ.
IC50 value: 7 nM
Target: mTOR
WYE-687 is a potent ATP-competitive mTOR inhibitor with an IC50 of 7 nM. It is well reported that the mammalian target of rapamycin (mTOR) is centrally involved in cell growth, metabolism, and angiogenesis. Significantly, the pyrazolopyrimidines were selective for mTOR over PI3Kα (>100-fold) and PI3Kγ (>500-fold) and were poorly active in a panel of 24 protein kinases. Unlike the rapalogs, WYE-687 acutely blocked mTORC2-dependent phosphorylation of AKT in vitro and in vivo. In various cancer cells, WYE-687 inhibited the mTORC1 substrate P-S6K(T389) and mTORC2 substrate P-AKT(S473) at submicromolar concentrations without significant inhibition of P-AKT(T308). WYE-687 was identified as an ATP-competitive, and selective inhibitor of mTOR kinase activity.


1:Concurrent inhibition of mTORC1 and mTORC2 by WYE-687 inhibits renal cell carcinoma cell growth in vitro and in vivo. Pan XD, Gu DH, Mao JH, Zhu H, Chen X, Zheng B, Shan Y.PLoS One. 2017 Mar 3;12(3):e0172555. doi: 10.1371/journal.pone.0172555. eCollection 2017. PMID: 28257457 Free PMC Article
2:Preclinical evaluation of WYE-687, a mTOR kinase inhibitor, as a potential anti-acute myeloid leukemia agent. Cheng F, Wang L, Shen Y, Xia J, Chen H, Jiang Y, Lu M.Biochem Biophys Res Commun. 2016 Feb 5;470(2):324-30. doi: 10.1016/j.bbrc.2016.01.054. Epub 2016 Jan 11. PMID: 26792718
Related Products
  • CAS No. :154447-38-8
    Product Name:

    LY 303511

    Cat No: I001951 View details
  • CAS No. :1092351-67-1
    Product Name:

    PP242

    Cat No: I000380 View details
  • CAS No. :1251156-08-7
    Product Name:

    XL388

    Cat No: I000999 View details
  • CAS No. :572924-54-0
    Product Name:

    Deforolimus

    Cat No: I004137 View details